Form 4 Filing for IN8BIO, INC.

This filing details a transaction by Patrick McCall, the Chief Financial Officer of IN8BIO, INC. On December 22, 2025, McCall acquired 7,247 shares of common stock at a price of $1.38 per share. Following this transaction, McCall now owns 9,482 shares. It is important to note that the reported share quantities have been adjusted to reflect a 1-for-30 reverse stock split that was effective on June 3, 2025.